Related Experiment Videos
Antihypertensive drugs in the elderly--the evidence of benefit
1Department of Medicine and Therapeutics, University of Glasgow, Scotland, UK. ts39u@clinmed.gla.ac.uk
Insights
For elderly patients with hypertension, thiazide diuretics are the recommended first-line treatment. This evidence-based approach prioritizes established therapies for cardiovascular risk reduction.
Area of Science:
- Geriatric Medicine
- Cardiovascular Pharmacology
- Clinical Hypertension Management
Background:
- Hypertension is a primary risk factor for cardiovascular disease, a leading cause of mortality in the elderly.
- Effective management of hypertension in older adults is a critical clinical goal.
- The expanding array of antihypertensive medications necessitates an evidence-based selection process.
Purpose of the Study:
- To review 'hard' outcome data for major antihypertensive drug classes in the elderly population.
- To categorize drug classes based on supporting evidence: established, emerging, and add-on therapies.
- To guide the evidence-based prescribing of antihypertensives for elderly patients.
Main Methods:
- Systematic review of clinical trial data focusing on hard cardiovascular outcomes.
- Analysis of efficacy and safety profiles of different antihypertensive drug classes in older adults.
- Categorization of therapies based on the strength of evidence for their use in the elderly.
Main Results:
- Thiazide diuretics demonstrate strong evidence as a preferred first-line therapy for hypertension in the elderly.
- Established therapies are supported by robust outcome data.
- Ongoing trials are evaluating newer agents like ACE inhibitors and calcium-channel blockers.
Conclusions:
- Current evidence supports thiazides as the drug of first choice for elderly hypertension management.
- Alternative therapies may be indicated for coexisting conditions or when multiple agents are needed.
- Continued evaluation of emerging therapies is essential for optimizing treatment strategies.
Abstract:
Hypertension is a major cardiovascular risk factor. The commonest mode of death in the elderly is a cardiovascular one and so the treatment of hypertension in the elderly population is an important clinical objective. The choice of which antihypertensive drug to prescribe is expanding and an evidence-based approach should be applied. In recent years more studies have been carried out into the efficacy of the various antihypertensive drugs in the elderly. This review looks at the "hard" outcome data for each major drug class and their suitability for prescribing in the elderly. The differing drug classes are divided into 3 categories based on the weight of evidence supporting them--established, emerging, and add-on therapies. Currently, and until the publication of ongoing trials into newer therapies such as ACE inhibitors and calcium-channel blockers, outcome data suggests that thiazides remain the drug of first choice except where other therapies are indicated for coexistant conditions or more than one drug is required to achieve the desired response.